Background: Cognitive impairment is common in multiple sclerosis (MS) and may be subtle. The corpus callosum is essential for connectivity-demanding cognitive tasks and is significantly affected in MS, therefore it may serve as a marker for cognitive function. Objective: The objective of this paper is to longitudinally study the normalized corpus callosum area (nCCA) as a marker of cognitive function and disability in MS. Methods: Thirty-seven MS patients were followed from 1996 with follow-ups in 2004 and 2013. A healthy matched control group was recruited. The Expanded Disability Status Scale (EDSS) and Symbol Digit Modalities Test (SDMT) were assessed. The nCCA was measured on T2-weighted images. Volumetry was performed with FreeSurfer. Results: Disease duration spanned five decades (1.6-46 years). Annual corpus callosal atrophy rate decreased with disease duration. nCCA was strongly correlated with SDMT (r = 0.793, p < 0.001) and moderately correlated with EDSS (r = -0.545, p < 0.001) after adjusting for disease duration, age and sex. The correlations of brain parenchymal fraction, white matter fraction, gray matter fraction and normalized lesion volume were less strong. Conclusions: The nCCA correlates well with physical and cognitive disability in time perspectives close to two decades, outperforming volumetric measurements. The nCCA is fast and could be feasible for clinical implementation where it may help identify patients in need of neuropsychological evaluation.
Introduction
In multiple sclerosis (MS), demyelination, axonal loss and neural degeneration lead to typical focal neurological symptoms, but also to diffuse neurological dysfunction such as cognitive impairment, which affects 43%-70% of MS patients and leads to a decreased quality of life. 1,2 MS has heterogeneous clinical outcomes, and predictors of the outcome are important for optimizing treatment, monitoring and support. 3 Although magnetic resonance imaging (MRI) is essential in the diagnosis and monitoring of MS, there is often a large discrepancy between the radiological findings and the patients' clinical state. 4 Volumetric MRI measurements show stronger correlations with disability and cognitive performance than conventional radiological findings, but volumetry is not used routinely owing to its need for laborious image processing. 5 There is thus a need for uncomplicated MRI biomarkers, which is why measurements of strategic structures such as the corpus callosum have come into focus. Since the corpus callosum provides interaction between the two cerebral hemispheres, it is of special importance in complex cognitive tasks. 6 The corpus callosum is notably affected in MS by focal lesions and Wallerian degeneration owing to its high myelin content, while it is normally relatively resistant to age-related changes in healthy individuals. [7] [8] [9] [10] Corpus callosum morphology is therefore a promising sensitive marker for MS pathology. [11] [12] [13] [14] [15] There are two manual methods for quantifying corpus callosal atrophy, corpus callosum area (CCA) and corpus callosum index (CCI). Both can easily be measured on sagittal MRI sequences. 11, 14 CCA and CCI cross-sectionally correlate well with information processing speed measured by the Symbol Digit Modalities Test (SDMT) and Paced Auditory Serial Addition Test (PASAT). [16] [17] [18] [19] [20] CCA also correlates with the Expanded Disability Status Scale (EDSS) in five-and nine-year long perspectives, but there are conflicting results in terms of the performance as an independent predictor of physical disability. [11] [12] [13] 21 Consequently, two-dimensional (2D) measurements of the corpus callosum have shown promising results as suitable biomarkers for disability and cognitive function in MS. However, the progression of corpus callosal atrophy in MS and its correlation with disability and cognitive function in time perspectives spanning over more than a decade remains to be explored.
The primary aim of this longitudinal study was to study whether corpus callosum atrophy correlates with physical and cognitive disability during long-term follow-up spanning over five decades of disease duration. A secondary aim was to compare the performance of the nCCA to volumetric measurements in this context.
Methods

Study population
The ethics review board in Stockholm approved the study and informed written consent was obtained. The patients were recruited in 1996 from the outpatient clinic at the MS center of Karolinska University Hospital, Stockholm, Sweden. The cohort of 37 patients had a follow-up in 2004, of whom 23 patients remained at the follow-up in 2013. Mean follow-up time for the remaining patients in 2013 was 17.2 years. Disease duration was calculated from the onset of MS symptoms to the date of each MRI scan and spanned from 1.6 to 46 years in the study. In 2013, a group of 23 healthy age-and sex-matched controls was recruited.
The participant demographics are described in Table  1 . Of the patients lost to follow-up in 2013, five were deceased, three had developed contraindications for MRI, three were bedridden, and three declined participation. Notable is that all patients with primary progressive MS (PPMS) were deceased at the last follow-up. Of the 23 patients followed to 2013, a majority entered the study with relapse-remitting MS, but 17 patients converted to secondary progressive MS (SPMS) during the study, with a majority having SPMS at the end. During the study, eight patients started, six patients switched and eight individuals discontinued disease-modifying treatment.
Clinical and neuropsychological assessments
Disability assessments were performed by a senior consultant in neurology (SF) using the EDSS, blinded to the radiological and neuropsychological parameters. Neuropsychological testing was performed in conjunction with the MRI examinations by a neuropsychologist (GB), blinded to the neurological assessment and the radiological parameters. The neuropsychological Figure Copy . At the previous time points only SDMT were available for the cohort, which is why the emphasis in this longitudinal perspective is on SDMT. SDMT scores were presented as z-scores tabulated according to normative data for age, gender and educational level. 22 An abnormal result was defined as a deviation of >2 standard deviations from the mean of the norm.
MRI protocol
Image acquisition was performed at Karolinska University Hospital, Stockholm, Sweden. A sagittal T2-weighted sequence was acquired for the CCA measurements and a three-dimensional T1-weighted gradient echo (MPRAGE) sequence was obtained for volumetric analysis in 2004 and 2013. MRI sequences were harmonized in order to optimize the comparability of the result and are described in Supplementary  Table 1 . Imaging was performed with three 1.5 T MRI scanners because of the need for successive replacements of the MRI equipment at the radiology department during the study span of 17 years.
Radiological assessment
The nCCA was manually outlined on sagittal T2-weighted MRI sequences using integrated tools in the Picture Archiving Communicating System (PACS; IDS7, Sectra, Sweden) on a radiological workstation by a neuroradiologist (JM). The CCA was normalized (nCCA) to the midsagittal intracranial skull surface area. An example of the outlining is seen in Figure 1 .
To report on the robustness of the nCCA method, intra-rater reliability was studied at a second rating session performed six months later, and inter-rater agreement by comparison to a second rater, a resident in radiology (TG). All ratings were performed in a randomized order blinded to the clinical data, previous ratings and each other's ratings.
Volumetric analysis
Volumetric segmentation was performed using the longitudinal stream of FreeSurfer (Mac version 5.3.0, Harvard University). Technical details of these procedures can be found in prior publications. 23 The MPRAGEs of two patients (one at each time point) were excluded from the volumetric analysis due to motional artifacts. Additionally, fluid-attenuated inversion recovery (FLAIR-) and MPRAGE-based lesion segmentations were performed using Lesion Segmentation Toolbox (version 1.2.3) for SPM 8 (Mac Intel 64-bit version, University College London), an automatic software for MS lesion segmentation utilizing a lesion growth algorithm. 24 All segmentations were visually quality controlled and manually edited as necessary by a resident in radiology (TG). Measurements were normalized to the intracranial volume in order to reduce any scaling effects in between the scans. The volumetrics used were brain parenchymal fraction (BPF), gray matter fraction (GMF), white matter fraction (WMF) and normalized lesion volume (nLV).
Statistical analysis
Statistical analysis was performed using SPSS 22.0 (IBM, 2013). The Shapiro-Wilk normality test was used to test for normality of distribution. Independent t-tests were used for comparison of parametric data and the Mann-Whitney U for non-parametric variables. The Pearson correlation coefficient was used for parametric data, while Spearman rank correlation coefficient was used for non-parametric data. Correlation coefficients (r) of 0.2-0.4, 0.4-0.6, 0.6-0.8 and 0.8-1.0 were considered to be weak, moderate, strong and very strong, respectively. Intra-and inter-rater agreement analyses were performed using intraclass correlation coefficient (ICC) for absolute agreement on single measures. An α-level of 0.05 was determined to be statistically significant, which after Bonferroni correction with a factor of 7 for multiple comparisons was equivalent to 0.0071. 
Results
Cognitive and physical disability EDSS scores increased with disease duration with a moderate correlation after adjustments for age and sex (r = 0.411, p < 0.001). A plateauing effect was noticed with increasing disease duration; however, large individual differences were seen, as illustrated in Figure 2 .
At the neuropsychological testing in 2013, one patient declined participation, four patients performed normally and 18 patients (82%) performed subnormally. Some patients performed below normal in two (N = 5), three (N = 2) or four (N = 2) of the five tests, respectively. A clinical and radiological comparison of patients with normal and subnormal test results are presented in Table 2 . One patient was unable to perform SDMT in 2013 because of severely impaired visual acuity. Generally, there was a decline in SDMT test results over the length of the study with large inter-individual heterogeneity, and SDMT was only weakly associated with disease duration (-0.373, p < 0.001).
Radiological markers in controls
The nCCA and BPF differed significantly between patients and the control group, while the other volumetric measurements only showed trends. Comparisons of all radiological measurements are reported in Table  3 . The nCCA was not correlated with age in the control group (r = -0.035, p = 0.878), while BPF, GMF and WMF all showed trends in terms of decreasing with age (r = -0.517, p = 0.014; r = -0.225, p = 0.314 and r = -0.416, p = 0.054).
CCA in MS patients
Intra-rater and inter-rater ICC for nCCA was excellent (0.961 and 0.959, both p < 0.001).
The nCCA tended to decrease with increasing disease duration, corrected for age and sex (r = -0.177, p = 0.087). The CCA decreased by 6.6 mm 2 (1.2%) annually in the 23 patients followed to 2013. The annual corpus callosal atrophy rate was higher from baseline to 2004 than from 2004 to 2013, 8.6 mm 2 (1.6%) and 4.4 mm 2 (0.9%), respectively, illustrated in Figure 3 .
The nCCA showed a strong correlation with SDMT (r = 0.793, p < 0.001) and a moderate correlation with EDSS (r = -0.545, p < 0.001) after adjusting for disease duration, age and sex. As shown in Table  4 , these correlations remained significant after correcting for multiple comparisons. From a longitudinal perspective, nCCA at study entry in 1996 and at the first follow-up in 2004 showed moderate to strong correlations with SDMT in 2013. The results for each time point and measurement are reported in Table 5 . In order to study the predictive correlation of the measurements, the correlations with the end measurements were then adjusted for SDMT and EDSS at each time point. This showed that there were no statistically significant predictive correlations of any of the radiological measurements with the end SDMT/ EDSS results, presented in Supplementary Table 2 .
Volumetry in MS patients
In accordance with nCCA, the volumetric measurements overall showed stronger correlation with SDMT than EDSS. As shown in Table 4 , GMF and nLV were strongly correlated with SDMT and moderately correlated with EDSS after adjusting for disease duration, age and sex. From a longitudinal perspective, only nLV in 2004 showed a significant correlation with the SDMT in 2013. The results of all volumetric measurements at all time points are reported in Table 5 .
Discussion
This longitudinal study, reflecting five decades of disease duration, is to our knowledge the first study to demonstrate that corpus callosum atrophy remains strongly associated with decreased performance in cognitively demanding information processing tasks, even in time perspectives close to two decades. Interestingly, in this longitudinal perspective the corpus callosal atrophy rate decreased with increasing disease duration, both in absolute and relative numbers. This plateauing effect was also true for EDSS, illustrated in Figures 2  and 3 . This suggests that the disease processes leading to atrophy in areas with a high axonal content are more aggressive in the first stages of the disease, which encourages early treatment in MS. This finding is supported by previous histopathological data showing that axonal damage is most extensive in early stages of the disease and decreases over time. 25 Additionally, there was no correlation between nCCA and age in the control group, while all volumetric measurements showed trends toward decreasing with age. This is in line with previous studies showing that corpus callosum is relatively resistant to age-dependent change, and supports the claims that nCCA could be quite a specific marker for cognitive impairment. [8] [9] [10] Furthermore, nCCA outperformed all volumetric measurements in terms of correlation with both cognitive and physical disability as suggested by earlier cross-sectional and shorter longitudinal studies. 13, 15, 20 Both nCCA and the volumetric measurements were more strongly correlated with SDMT than EDSS, which is in line with previously published data. [11] [12] [13] 20, 21 In previous studies, CCA has mainly been obtained on T1-weighted sequences, while T2-weighted images were used in this study. Our results suggest that T2 outlining is also feasible. An important advantage of nCCA is that it is fast, easy and robust, which makes it feasible and lowers the threshold for clinical implementation.
None of the radiological markers had a predictive correlation with the clinical scores at the end of the study after adjusting for the SDMT/EDSS at the respective time points. Although discouraging, this reflects the difficulty of identifying independent predictive markers for the heterogeneous clinical outcome in MS.
This study has several strengths. One is the follow-up time of more than 17 years, reflecting five decades of disease duration and a large span of disability (EDSS 0.0-8.5). The original composition of the cohort reflects a typical panorama of an outpatient MS clinic with various disease durations and all subtypes of MS. However, as expected, a majority of patients converted to SPMS during the study and were cognitively impaired at the last follow-up because of the progression of the disease. No subgroup analysis based on MS subtype was performed owing to the limited sample size. Another strength of this study is the experience and consistency of the raters that remained the same throughout the study.
One limitation of this study is that different MRI scanners were used owing to the need for continuous hardware upgrades in the clinical setting. However, efforts were made to harmonize the MRI acquisitions, and the field strength remained the same. As an additional precaution to reduce scaling effects, all radiological measurements were normalized to the skull size. This being said, volumetrics using FreeSurfer have good test-retest reliability across scanner manufacturers and field strengths, and the longitudinal stream additionally increases reliability by performing processing steps with common information from a within-subject template. 23 Another limitation is the relatively small cohort size since it was formed in 1996, when MRI availability was more limited. Despite this, the main results were highly significant. Losses to follow-up were unfortunately inevitable because of the study length, and the loss of all PPMS patients to 2013 limits the generalizability of the latest measurements. Lastly, the lack of longitudinal control group data is another limitation, but the relative resistance of CCA to age-dependent change is in alignment with previous studies. [8] [9] [10] For example, a recent cross-sectional study of 856 healthy individuals found that corpus callosum volume was reduced by only 0.3% per year of age. 10 In summary, the nCCA correlates well with physical and cognitive disability, even in time perspectives close to two decades, and outperforms more advanced volumetric measurements. Owing to its fast and simple nature, the nCCA could be feasible for clinical implementation where it may assist in identifying patients in need of neuropsychological evaluation and thereby help to optimize their care.
